• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

73.44 +0.35 (+0.48%)
Streaming Delayed Price Updated: 9:37 AM EST, Feb 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 112,663
Open 73.42
Bid (Size) 73.38 (500)
Ask (Size) 73.50 (200)
Prev. Close 73.09
Today's Range 72.53 - 73.46
52wk Range 54.11 - 91.87
Shares Outstanding 384,800,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars ↗
Today 9:35 EST
It's another reason to invest in this exciting medical device stock. 
Via The Motley Fool
News headline image
Dexcom Announces Upcoming Conference Presentation
Today 8:30 EST
From DexCom, Inc.
Via Business Wire

Performance

YTD
+10.4%
+10.4%
1 Month
+0.1%
+0.1%
3 Month
+19.0%
+19.0%
6 Month
-3.5%
-3.5%
1 Year
-19.1%
-19.1%

More News

Read More
News headline image
The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off
February 24, 2026
Via Finterra
Topics Artificial Intelligence Economy Initial Public Offering
Dexcom Inc (NASDAQ:DXCM) Beats Q4 Profit Estimates Despite Revenue Shortfall ↗
February 12, 2026
Via Chartmill
DexCom Inc. (NASDAQ:DXCM) Combines Strong Fundamentals with Bullish Chart Pattern ↗
January 20, 2026
Via Chartmill
News headline image
The 5 Most Interesting Analyst Questions From DexCom’s Q4 Earnings Call
February 19, 2026
Via StockStory
Topics Earnings
News headline image
Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues
February 18, 2026
Via MarketMinute
Topics Earnings
Top S&P500 movers in Friday's session ↗
February 13, 2026
Via Chartmill
Friday's session: top gainers and losers in the S&P500 index ↗
February 13, 2026
Via Chartmill
News headline image
Why Is DexCom (DXCM) Stock Rocketing Higher Today
February 13, 2026
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Soleus Adds a Significant Number of Celcuity Shares ↗
February 13, 2026
Via The Motley Fool
News headline image
DXCM Q4 Deep Dive: New Product Launches and International Strategy Drive Outlook
February 13, 2026
Via StockStory
News headline image
DexCom (DXCM) Q4 2025 Earnings Call Transcript ↗
February 12, 2026
Via The Motley Fool
Topics Earnings Economy
News headline image
DexCom (NASDAQ:DXCM) Exceeds Q4 CY2025 Expectations
February 12, 2026
Via StockStory
News headline image
Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results
February 12, 2026
From DexCom, Inc.
Via Business Wire
News headline image
Earnings To Watch: DexCom (DXCM) Reports Q4 Results Tomorrow
February 10, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
1 High-Flying Stock with Impressive Fundamentals and 2 We Ignore
February 08, 2026
Via StockStory
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
February 05, 2026
Via StockStory
News headline image
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management
February 04, 2026
From Dexcom, Inc.
Via Business Wire
News headline image
3 Profitable Stocks for Long-Term Investors
January 28, 2026
Via StockStory
News headline image
Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.
January 27, 2026
From DexCom, Inc.
Via Business Wire
News headline image
2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore
January 26, 2026
Via StockStory
News headline image
Abbott Laboratories Shares Plunge 10% Following Q4 Revenue Miss and Diagnostics Weakness
January 22, 2026
Via MarketMinute
Topics Economy
News headline image
Abbott Shares Slump as Revenue Miss and Exact Sciences Acquisition Jitters Overshadow Earnings Beat
January 22, 2026
Via MarketMinute
Topics Earnings Economy
News headline image
1 Growth Stock Down 19% to Buy Right Now ↗
January 21, 2026
Via The Motley Fool
Topics Product Recall

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?
Yes, DexCom, Inc. - Common Stock is publicly traded.
What exchange does DexCom, Inc. - Common Stock trade on?
DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DexCom, Inc. - Common Stock?
The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market
What is the current price of DexCom, Inc. - Common Stock?
The current price of DexCom, Inc. - Common Stock is 73.44
When was DexCom, Inc. - Common Stock last traded?
The last trade of DexCom, Inc. - Common Stock was at 02/25/26 09:37 AM ET
What is the market capitalization of DexCom, Inc. - Common Stock?
The market capitalization of DexCom, Inc. - Common Stock is 28.26B
How many shares of DexCom, Inc. - Common Stock are outstanding?
DexCom, Inc. - Common Stock has 28B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap